Literature DB >> 23478421

Cardiovascular disease: Is CABG really better than PCI in dialysis patients?

Christoph Wanner1, Kitty J Jager.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23478421     DOI： 10.1038/nrneph.2013.41

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  6 in total

Review 1.  Comparative effectiveness research: what is it and why do we need it in nephrology?

Authors:  Tara I Chang; Wolfgang C Winkelmayer
Journal:  Nephrol Dial Transplant       Date:  2012-06       Impact factor: 5.992

Review 2.  Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention in patients with end-stage renal disease.

Authors:  Hui Zheng; Song Xue; Feng Lian; Ri-Tai Huang; Zhen-Lei Hu; Yong-Yi Wang
Journal:  Eur J Cardiothorac Surg       Date:  2012-07-09       Impact factor: 4.191

3.  Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD.

Authors:  Tara I Chang; David Shilane; Dhruv S Kazi; Maria E Montez-Rath; Mark A Hlatky; Wolfgang C Winkelmayer
Journal:  J Am Soc Nephrol       Date:  2012-12       Impact factor: 10.121

Review 4.  Instrumental variable analysis.

Authors:  Vianda S Stel; Friedo W Dekker; Carmine Zoccali; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2012-07-24       Impact factor: 5.992

5.  Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.

Authors:  Gengo Sunagawa; Tatsuhiko Komiya; Nobushige Tamura; Genichi Sakaguchi; Taira Kobayashi; Takashi Murashita
Journal:  Ann Thorac Surg       Date:  2010-06       Impact factor: 4.330

6.  Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.

Authors:  Mark A Hlatky; Derek B Boothroyd; Dena M Bravata; Eric Boersma; Jean Booth; Maria M Brooks; Didier Carrié; Tim C Clayton; Nicolas Danchin; Marcus Flather; Christian W Hamm; Whady A Hueb; Jan Kähler; Sheryl F Kelsey; Spencer B King; Andrzej S Kosinski; Neuza Lopes; Kathryn M McDonald; Alfredo Rodriguez; Patrick Serruys; Ulrich Sigwart; Rodney H Stables; Douglas K Owens; Stuart J Pocock
Journal:  Lancet       Date:  2009-03-19       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.